Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Thomas, Timothy P (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S045000, C514S046000, C536S026120, C544S228000
Reexamination Certificate
active
07977343
ABSTRACT:
Novel adenine derivatives of the formula (I), in which R1, R2, R3, X and Y have the meanings indicated in Claim1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
REFERENCES:
patent: WO 01/72779 (2001-10-01), None
patent: WO 03/037860 (2003-05-01), None
patent: WO 2006/075095 (2006-07-01), None
(Vippagunta, et al. Advanced Drug Delivery Reviews, 48, 2001, p. 18) Wolff, Manfred E., Ed. Burgers Medicinal Chemistry and Drug Discovery—Fifth Edition, New York: John Wiley & Sons,1996, vol. 1, pp. 975-976).
Buchstaller Hans-Peter
Cezanne Bertram
Eggenweiler Hans-Michael
Wolf Michael
Cornet Jean
Merck Patent Gesellschaft mit beschrankter Haftung
Millen White Zelano & Branigan P.C.
Thomas Timothy P
LandOfFree
Adenine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2704516